Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444378 · ClinicalTrials.gov registry record · NA
Absolute Pro® MOMENTUM™
A NA study of Peripheral Artery Disease and Peripheral Vascular Disease, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT01444378 is a NA study of Peripheral Artery Disease and Peripheral Vascular Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 141 participants, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01444378, a NA study of Peripheral Artery Disease and Peripheral Vascular Disease, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the safety and effectiveness of the Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery (SFA) and/or the native proximal popliteal artery (PPA). CAUTION: Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems are investigational devices. Limited by Federal (U.S.) law to investigational use only.
Conditions Studied
Interventions
- DEVICE Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems
Study Locations (1)
California
- Abbott Vascular - Santa Clara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01444378
The ClinicalTrials.gov registry entry for NCT01444378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (14% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems is the first listed.
NCT01444378 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01444378 about?
NCT01444378 is a clinical study titled "Absolute Pro® MOMENTUM™". To evaluate the safety and effectiveness of the Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery (SFA) and/or ...
What is the current status of trial NCT01444378?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2011-10. Estimated completion is 2015-05.
What conditions does trial NCT01444378 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, Peripheral Vascular Disease.
What interventions are being tested in trial NCT01444378?
The interventions under investigation include: Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems (DEVICE).
Who is sponsoring clinical trial NCT01444378?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01444378 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.